SARS-CoV-2 Induced CTPA Proven Pulmonary Embolism: A Case Report

Abstract

SARS-CoV-2 causing coronavirus disease 2019 emerged in Wuhan, China in December 2019 as a cluster of atypical pneumonia and now it has been declared a pandemic by the World Health Organization and has caused the death of approximately one million people. Coagulopathy has been found in association with COVID-19 due to inflammation, endothelial damage, hypoxia, and diffuse intravascular coagulation (DIC). Here, we discussed a 60-year-diabetic, hypertensive female who was initially presented as a case COVID-19 and was later on diagnosed as pulmonary embolism secondary to COVID-19.